Afghan Repatriation Delayed? Taliban, TTP & U.S. – A New Game Begins!
[emebd]https://youtu.be/3aT9rg5_jQE[/emebd]
KPRA Collects Rs. 37.37 Billion in 9 Months, Marking 41% Growth
Peshawar: The Khyber Pakhtunkhwa Revenue Authority (KPRA) has demonstrated remarkable performance by collecting Rs. 37.37 billion in the first nine months of the current fiscal year, marking a 41% increase compared to the same period last year.
According to KPRA’s spokesperson, the authority collected Rs. 26.58 billion during the corresponding period last year, and this year, revenue surged by Rs. 10.79 billion.
Detailed breakdown shows that Rs. 28.8 billion were collected from Sales Tax on Services, and Rs. 8.57 billion from the Infrastructure Development Cess.
Last year, collections under the same heads stood at Rs. 22.8 billion and Rs. 3.74 billion, respectively, indicating a 26% rise in Sales Tax and a remarkable 129% increase in the Cess.
KPRA Director General Fauzia Iqbal praised the dedication of her team and said the authority is on track not only to achieve but to exceed the annual target of Rs. 47 billion by June.
She also extended gratitude to the taxpayers for their trust, and to Chief Minister Ali Amin Gandapur and Finance Advisor Muzammil Aslam for their continued support and guidance in achieving institutional goals.
Peshawar High Court Cancels KP Health Dept’s Biased Multi-Million Tender
Peshawar High Court Nullifies Multi-Million Rupee Health Department Tender Over Bias and Lack of Transparency
Peshawar: The Peshawar High Court has nullified a multimillion-rupee medicine procurement tender issued by the Khyber Pakhtunkhwa Health Department, declaring it biased and non-transparent.
A two-member bench comprising Justice Arshad Ali and Justice Khurshid Iqbal issued the verdict while hearing a petition challenging the tendering process.
Petitioner’s counsel, Shumail Ahmad Butt, argued that the contract was awarded to Frontier Dextose Limited, a company that had previously been blacklisted for supplying fake and substandard medicines. He further claimed that procurement rules were deliberately manipulated to benefit the disqualified firm.
The court was presented with laboratory testing reports confirming the dubious reputation of the company.
After reviewing the arguments, the court ruled that a key clause was intentionally omitted from the tender criteria to favor the blacklisted company — a move deemed unlawful and unethical.
The court has ordered the immediate cancellation of the tender and directed the Health Department to restart the procurement process with full transparency and fair competition.
The bench stressed that no corruption or favoritism will be tolerated in purchases made from public funds, adding that favoring blacklisted firms is tantamount to endangering human lives.